Skip to main content

CTXR

Citius Pharmaceuticals, Inc.

Company with tickers: CTXR

CIK
1506251
CUSIP
17322U306
Shares Outstanding
27,452,570
13F Activity (30d)
3 filings 2 filers

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Recent news

Past events

Date Event Type
2025-01-29 The MicroCap Conference 2025 Conference
2025-01-29 The MicroCap Conference 2025 Conference
2024-10-17 Maxim Group 2024 Virtual Healthcare Summit Event
2024-08-14 Sidoti Micro Cap Conference Presentation Conference
2024-08-13 Investor Call Event
2024-06-13 Sidoti Small Cap Virtual Conference Conference
2024-06-03 Investor Call to Discuss Topline Results of Phase 3 Trial of Mino-Lok Antibiotic Lock Solution Event
2024-05-15 EF Hutton Annual Global Conference Conference
2023-10-19 Citius Pharmaceuticals Presentation at ThinkEquity Conference Conference
2023-10-12 Citius Pharmaceuticals Presentation at Dawson James Small Cap Growth Conference Conference
2023-06-21 Citius Pharmaceuticals' Fireside Chat at Maxim Group's Virtual Healthcare Conference Conference
2022-12-11 Citius Pharmaceuticals to Present at the 64th American Society of Hematology (ASH) Annual Meeting Shareholder meeting
2022-10-26 Citius Pharmaceuticals to Present at the ThinkEquity Conference on October 26, 2022 Conference
2022-10-12 Citius Pharmaceuticals to Present at Dawson James Securities Small Cap Growth Conference on October 12, 2022 Conference
2022-09-12 Citius Pharmaceuticals, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference Conference
2022-04-18 Citius Pharmaceuticals to Present at the NobleCon18 Investor Conference on April 20, 2022 Conference
2022-03-03 Citius Pharmaceuticals, Inc. to Present at March 2022 Conferences Conference
2022-01-10 Citius Pharmaceuticals, Inc. to Present at Upcoming Virtual Conferences Conference
2021-11-11 Key Opinion Leader Webcast on the Compelling Need to Salvage Central Venous Catheters in CLABSI Patients Webcast
2021-10-21 Dawson James Securities 6th Annual Small Cap Growth Conference Conference
2021-10-20 Investor Webcast to Discuss the Acquisition of Late Phase 3 Cancer Immunotherapy I/ONTAK (E7777) Webcast
2021-09-13 Citius Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15 Conference
2021-05-25 International Society for Cell and Gene Therapy Poster Presentation Presentation
2021-05-24 Special Meeting of Stockholders Shareholder meeting
2021-05-18 Gabelli Funds Virtual Microcap Symposium Event

Source: https://www.citiuspharma.com/investors/